Image of Sartan- AT receptor interactions: evidence for insurmountable antagonism and inverse agonism

LITERATURE

Sartan- AT receptor interactions: evidence for insurmountable antagonism and inverse agonism


Sartans are non-peptide AT1 receptor antagonists used to treat hypertension and related pathologies. Their effects on the G protein-dependent responses of angiotensin II (Ang II) were the same in vascular tissues and in isolated cell systems. All are competitive but,
when pre-incubated, they act surmountably (only rightward shift of the Ang II concentration-response curve) or insurmountably (also decreasing the maximal response). Insurmountable behaviour reflects the formation of tight sartan-receptor complexes; it is
often partial due to the co-existence of tight and loose complexes. Their ratio positively correlates with the dissociation half-life of the tight complexes and depends on the sartan: i.e. candesartan > olmesartan > telmisartan ≈ EXP3174 > valsartan > irbesartan >>
losartan. When AT1 receptors display sufficient basal activity (in case of receptor overexpression, mutation and, especially, tissue
stretching) sartans may also act as inverse agonists. This rather affects long-term, G protein-independent hypertrophic responses
leading to cardiovascular remodelling.


Availability

Canderin Duo-001Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Molecular and Cellular Endocrinology, 2009, 302 (2), pp.237
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous